Barbara Bonifacio

Dr. Barbara Bonifacio


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GPGilda Paternuosto
Gilda Paternuosto
AFAnna Flamigni
Anna Flamigni
MZMonica Zanier
Monica Zanier
BBBarbara Bonifacio
Barbara Bonifacio
GSGiulia Schillani
Giulia Schillani
AMAlessandra Maestro
Alessandra Maestro
Driven by technological advances and regulatory developments, the clinical trials industry is undergoing a period of transformation. Decentralized clinical trials (DCTs) promise to streamline processes, increase participant engagement and improve data quality. The pediatric clinical trial landscape is challenging, as participation in a clinical trial affects the whole family. DCTs allow for increased patient engagement, thereby improving trial quality and consequently drug safety. The Italian Medicines Agency (AIFA), in its quest for regulatory simplification and alignment with the European framework, has established comprehensive guidelines to facilitate these decentralized trials. The present work aims to delve into the regulations to understand the feasibility of conducting decentralized pediatric trials in Italy.